MOUNTAIN VIEW, Calif., April 26 /PRNewswire/ -- Pharsight Corporation , a leading provider of software and strategic services designed to optimize clinical drug development, today announced that it will release financial results for the fiscal fourth quarter and full year 2006 ended March 31, 2006 after the market closes on Tuesday, May 9, 2006. The Company will host a conference call and webcast on Wednesday, May 10, 2006 at 10:00 a.m. Pacific Time to discuss the Company’s fiscal fourth quarter and full year results, outlook for fiscal 2007, and current corporate developments. The dial-in number for the conference call is 800-240-4186 for domestic participants and 303-262-2143 for international participants.
A taped replay of the conference call will also be available beginning approximately one hour after the call’s conclusion and will remain available for seven days. This replay can be accessed by dialing 800-405-2236 for domestic callers and 303-590-3000 for international callers, using passcode 11058659#. To access the live webcast of the call, go to Pharsight’s website at www.pharsight.com. An archived webcast will also be available at www.pharsight.com.
About Pharsight Corporation
Pharsight Corporation develops and markets products and services that help pharmaceutical and biotechnology companies improve their decision-making in drug development and commercialization. By integrating scientific, clinical and business decision criteria into a dynamic, model-based methodology, Pharsight helps its customers optimize the value of their drug development programs and portfolios from discovery to post-launch marketing and any point in between. Pharsight uses computer-based drug-disease models, dynamic predictive market models, clinical trial simulation and advanced valuation models to create a continuously evolving view of its customers’ development efforts and product portfolios. This enables decision makers to make explicit value-driven trade-offs throughout the development and commercialization process. Pharsight Corporation is headquartered in Mountain View, California. Information about Pharsight is available at www.pharsight.com.
Pharsight Corporation
CONTACT: investors, Douglas Sherk, +1-415-896-6820, or JenniferBeugelmans, +1-415-896-6820, or media, Steve DiMattia, +1-917-620-0590, allof the EVC Group, for Pharsight Corporation
Web site: http://www.pharsight.com//
